<sec><title>Objective</title>To assess the prevalence and the profile of adverse events (AE) of natalizumab in patients with multiple sclerosis (MS).</sec><sec><title>Methods</title>Data collection from neurologists attending to patients with MS at specializ...

Full description

Bibliographic Details
Main Authors: Yára Dadalti Fragoso, Soniza Vieira Alves-Leon, Walter Oleschko Arruda, Margarete de Jesus Carvalho, Elizabeth Regina Comini-Frota, Éber Castro Corrêa, Maria Lucia Brito Ferreira, Paulo Diniz da Gama, Sidney Gomes, Marcus Vinicius Magno Gonçalves, Damacio Ramón Kaimen-Maciel, Maria Fernanda Mendes, Rogerio Rizo Morales, Andre Muniz, Pedro Rippel Salgado, Heloisa Helena Ruocco, Livia Brito Bezerra de Albuquerque, Joseph Bruno Bidin Brooks, Letícia Fêzer, Sergio Georgetto, Josiane Lopes, Fabíola Rachid Malfetano, Isabella D'Andrea Meira, Celso Luis Silva Oliveira, Francisco Tomaz Meneses de Oliveira, Fabiana Safanelli, Massaco Satomi
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2013-03-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
esclerose múltipla
natalizumabe
eventos adversos
anticorpos monoclonais
multiple sclerosis
natalizumab
adverse events
antibodies
monoclonal
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000300137

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000300137

Similar Items